跳至主要内容
临床试验/ACTRN12622001165774
ACTRN12622001165774招募中未知

Survivorship Care For Long-Term Responder Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC): Feasibility of a Multi-Disciplinary Team (MDT) Consultation

Chris O'Brien Lifehouse0 个研究点目标入组 30 人开始时间: 2022年8月24日最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Educational / counselling / training
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Histologically confirmed unresectable locally advanced or metastatic NSCLC
  • 2. Age >/= 18 years
  • 3. Able to understand, speak and read in English without the use of an interpreter
  • 4. >/= 6 months post initiation of current line of systemic therapy without radiological evidence of disease progression (stable disease, complete or partial response on CT performed within 3 months prior to enrolment; or complete or partial metabolic response, or stable disease on PET)
  • 5. Able to give informed written consent
  • 6. Access to computer with internet connection

排除标准

  • 1. Psychiatric comorbidity that would preclude participation in the study procedures
  • 2. A diagnosis of unresectable NSCLC that is being managed with ‘definitive’ or ‘curative’ intent (eg patients with stage III NSCLC undergoing concurrent chemoradiotherapy followed by consolidation durvalumab)

研究者

相似试验